Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2
国立国会図書館館内限定公開
収録元データベースで確認する
国立国会図書館デジタルコレクション
デジタルデータあり
公開元のウェブサイトで確認する
DOI[10.1186/s41182-021-00397-x]のデータに遷移します
全国の図書館の所蔵
国立国会図書館以外の全国の図書館の所蔵状況を表示します。
所蔵のある図書館から取寄せることが可能かなど、資料の利用方法は、ご自身が利用されるお近くの図書館へご相談ください
書誌情報
この資料の詳細や典拠（同じ主題の資料を指すキーワード、著者名）等を確認できます。
- 資料種別
- 記事
- 著者・編者
- Mya Myat Ngwe TunTakaya SakuraYasuteru Sakurai
- 出版年月日等
- 2022-01-07
- 出版年（W3CDTF）
- 2022-01-07
- タイトル（掲載誌）
- Tropical medicine and health
- 巻号年月日等（掲載誌）
- 50(6)
- 掲載巻
- 50(6)
- ISSN（掲載誌）
- 1349-4147
- ISSN-L（掲載誌）
- 1348-8945
- 本文の言語コード
- eng
- DOI
- 10.1186/s41182-021-00397-x
- 国立国会図書館永続的識別子
- info:ndljp/pid/12307900
- コレクション（共通）
- コレクション（障害者向け資料：レベル1）
- コレクション（個別）
- 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
- 収集根拠
- オンライン資料収集制度
- 受理日（W3CDTF）
- 2022-07-11T22:10:26+09:00
- 保存日（W3CDTF）
- 2022-07-11
- 記録形式（IMT）
- application/pdf
- オンライン閲覧公開範囲
- 国立国会図書館内限定公開
- デジタル化資料送信
- 図書館・個人送信対象外
- 遠隔複写可否（NDL）
- 可
- 掲載誌（国立国会図書館永続的識別子）
- info:ndljp/pid/12307894
- 連携機関・データベース
- 国立国会図書館 : 国立国会図書館デジタルコレクション
- 要約等
- コレクション : 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
- DOI
- 10.1186/s41182-021-00397-x
- 関連情報（URI）
- 参照
- Construction of 5-aminolevulinic acid synthase variants by cysteine-targeted mutation to release heme inhibition5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
- 参照
- Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndromeSugiyama, Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer TherapyN. CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor/ataxia syndrome5‐Aminolevulinic acid can ameliorate language dysfunction of patients with ATR‐X syndromeSARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolutionPreclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID195-amino levulinic acid inhibits SARS-CoV-2 infection in vitro5-Aminolevulinic acid regulates the inflammatory response and alloimmune reactionOral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron<i>In Vivo</i> Curative and Protective Potential of Orally Administered 5-Aminolevulinic Acid plus Ferrous Ion against MalariaPerspectives for Applying G-Quadruplex Structures in Neurobiology and NeuropharmacologyDiscovery of G-quadruplex-forming sequences in SARS-CoV-2G-quadruplex structures: in vivo evidence and functionmRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variantsSevere Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June–October 2020Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanismsG-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 TherapeuticsA Genomic Perspective on the Origin and Emergence of SARS-CoV-2Neurological Manifestations of COVID-19 (SARS-CoV-2): A ReviewNeutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited seraCase Reports: Safety, Tolerability, and Efficacy of 5-Aminolevulinic Acid Phosphate, an Inducer of Heme Oxygenase 1, in Combination with Sodium Ferrous Citrate for the Treatment of COVID-19 PatientsMolnupiravir, an Oral Antiviral Treatment for COVID-19Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrinsCo-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelopeSARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorG-quadruplex forming sequences in the genome of all known human viruses: A comprehensive guideDrug repositioning: identifying and developing new uses for existing drugsEscape from neutralizing antibodies by SARS-CoV-2 spike protein variantsClinical Pharmacokinetics of 5-Aminolevulinic Acid in Healthy Volunteers and Patients at High Risk for Recurrent Bladder CancerGenomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingClinical characteristics of asymptomatic and symptomatic patients with mild COVID-19heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-α/βGastrointestinal symptoms of 95 cases with SARS-CoV-2 infectionAminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for EnhancementThe G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IXCoronavirus disease 2019: What we know?Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptorEarly Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaRemdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialA global database of COVID-19 vaccinationsSafety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA)Targeting RNA G‐Quadruplex in SARS‐CoV‐2: A Promising Therapeutic Target for COVID‐19?Diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in JapanHealth-related Quality of Life and Undergraduate Nursing Students: A Narrative Review.
- 連携機関・データベース
- 国立情報学研究所 : CiNii Research
- 提供元機関・データベース
- 雑誌記事索引データベースCrossref科学研究費助成事業データベース科学研究費助成事業データベース科学研究費助成事業データベースCrossrefCrossref
- 書誌ID（NDLBibID）
- 12307900